Speech by Federal Chancellor Dr. Angela Merkel at the presentation of the 2021 report of the Expert Commission on Research and Innovation on February 24, 2021, as a video message:

Germany Angela Merkel · Former Chancellor of Germany

28 February 2021 · Presentation of the 2021 report of the Expert Commission on Research and Innovation

Context
Merkel delivered a video message at the presentation of the 2021 Expert Commission on Research and Innovation annual report on February 24, 2021.
Main themes
Innovation policy, research and development investment, digitalization, climate protection and energy transition, COVID-19 pandemic response, vaccine development and health sector innovation, artificial intelligence, quantum technologies, hydrogen technologies, federal structure and governance, BioNTech and German biotech industry, CRISPR/Cas gene editing
Duration
~11 min
39th percentile
Words
1,336
39th percentile
Sentences
76
50th percentile
Readability
56
80th percentile
Grade
9.6
17th percentile
Syntax
2.89
33rd percentile
Vocabulary
2.00
11th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Technological 29%29%
  • Economic 24%24%
  • Institutional 18%18%
  • Ceremonial 16%16%
  • Social 11%11%
  • Geopolitical 3%3%
  • Environmental 0%0%
  • Not in focus 0%

76 sentences in 13 paragraphs

Thank you, Professor Cantner! At this point, I would now receive the report. But we can show it to each other. Anja Karliczek also has it ready. We will, of course, read it.

In 2008, we were handed the first report. At that time, I spoke about how the innovation of that time should become a tradition. Today, I am receiving the 14th annual report from the expert commission; this time in a very special period. The fact that we have been able to rely on your expertise for so long makes me grateful. I believe it was right to establish an expert committee in the field of innovation policy that does not correspond to the area of the Council of Economic Experts and in which there is no assessment of basic research, but rather one that operates in the middle ground. Where does innovation also create value? You have repeatedly provided us with very important insights on this.

At the moment, we are in an exceptional situation. Therefore, you have expanded the scope of your report to look at the challenges in this exceptional situation while also giving us advice and guidance for the next legislative period. We want to use this crisis, which we have found ourselves in without fault, to also decisively initiate certain transformation processes. We have now become sufficiently acquainted with the calamities or shortcomings in the digital sector. The questions of innovation in the area of climate protection, along with everything that is associated with it, are on the agenda, as are questions of mobility and many questions regarding energy production and the entire economic model. You have rightly pointed out, for example, the hydrogen technologies that are so important.

It becomes clear that the federal structure of our country is not always – as I would like to put it – a driver of innovation, especially in the area of digitalization, but that it can sometimes be very cumbersome. We have also had to amend the Basic Law in connection with the Online Access Act in order to be able to operate across the various levels. We, as the federal government, have also invested a lot of money. For example, just today in the cabinet, we made decisions regarding the renewal and digitalization of the Central Foreigners' Register, which will hopefully enable seamless operations across federal levels starting next year.

We will invest 60 billion euros from our crisis-born stimulus and innovation program as a future package. This is also about speed – that the money is not used only in years, but really as quickly as possible; specifically for climate protection, for modern mobility, for the energy transition, and also for quantum technologies, AI, and so on.

The health sector has proven to be – as I would like to say – a treasure trove for innovation in Germany. Because with BioNTech and CureVac, we have two companies in Germany, actually still start-ups, that are now very successful internationally. However, it is also evident that the partnership with a large German company offers different possibilities than a partnership, for example, with an American corporation like Pfizer. We are very pleased that BioNTech can now produce vaccines in a relatively short time with its own facility in Marburg, thus also reducing its dependency to some extent.

The situation regarding vaccine development gives us, I think, an opportunity to refocus on the question of whether we want to become a bit more of the "pharmacy of the world" again; we were stronger in that role in the past, but have let much of it slip away. However, this requires an environment in which that is possible. In my early years in politics, I repeatedly dealt with insulin production, which also took an eternity in Germany. It is simply not enough to continuously increase investments in research and development. However, we have succeeded in doing so: from 2009 to 2019, by 72 percent. That is good. In 2019, we had a share of 3.17 percent of gross domestic product. In 2020, it is likely to be even a bit more, as the gross domestic product has collapsed. But we also want to reach the mark of 3.5 percent by 2025 with better economic growth and a better gross domestic product. You are absolutely right, that is a necessary but not yet sufficient condition for conducting progressive or successful innovation policy.

We are setting priorities. One priority is the topic of artificial intelligence, now also with hubs. Time and again, we come – this also applies to quantum technology, which is another focus – to the point that we must pay attention to sufficient computing capacities, meaning we really need modern computers. That is a priority.

In addition to the fact that you urge us to bundle competencies and create synergy effects, you have set another focus. You are addressing the topic of CRISPR/Cas in great detail. This topic is known as the gene scissors. The question of how this fits into all things genetic engineering is highly contested. We have regulations in Eastern Europe that do not make our work any easier here. The European Union must also rethink in this regard. We will, of course, continue to support this groundbreaking medical basic research. We are also very proud that with Dr. Charpentier, one of the leading scientists in the world is working in Germany. Together with Reinhard Genzel, we had two Nobel Prize winners last year; in different fields, not both in CRISPR/Cas. That is something to be proud of.

But, as I said, we must also always create a suitable environment. Let us think of the beginnings of BioNTech. When we first spoke of mRNA vaccines, half of Parliament was immediately in an uproar about whether new genes were somehow being implanted. In the meantime, this has turned into a success story; and no one wants to receive a vector vaccine anymore. It can change so quickly. In a society that is not so well educated, it is possible to generate very quickly positive and negative feelings for certain things. Perhaps we can now also use this momentum for the entire field of genetic technologies. Because if we were to fall behind in this area, it would be very bad.

You have also made it clear that money and research institutions are one thing. The other is that an agile working method is necessary, for which we also need people. Given the demographic change, the question of personnel, training, and further education is, of course, of crucial importance. We have a shortage of skilled workers in the area of digital education and too little openness to the natural sciences. We have been advocating for STEM subjects for years – with moderate success, I would say. But when you look at the researchers at BioNTech or CureVac or elsewhere, it may be a certain encouragement for young people to engage in this area and acquire competencies, rather than just being afraid that it involves thick boards and that it is very difficult in their studies and that they do not make real progress. I think we need to keep saying this, especially to girls and young women. Because we can still use more young talent in that area.

Overall, your report is a wonderful treasure trove for us and our further work. I think I can also say this on behalf of Anja Karliczek, who has to implement much of it. We know that we have done some things quite well. But with "quite well," one does not get far in today's world. When you see the dynamics in the United States, in China, or also in South Korea, Israel, and other countries around the world, you understand that one cannot do enough, if in doubt, even more resolutely and more quickly.

Thank you for your encouragement and your suggestions! Thank you for your work that you have put into this report! And as is often said today: Stay healthy!